Log in
Diseases of the nervous system

Dysautonomia

Dysautonomia refers to dysfunction of the autonomic nervous system, affecting the regulation of heart rate, blood pressure, digestion, temperature, and other involuntary functions. It can be primary (idiopathic or genetic) or secondary to conditions like diabetes, Parkinson disease, or autoimmune disease, and disproportionately affects young women when presenting as postural orthostatic tachycardia syndrome (POTS). The single most testable fact: orthostatic vital signs (a sustained drop in blood pressure or excessive rise in heart rate on standing) are the key bedside test that distinguishes neurogenic orthostatic hypotension from POTS.

Practice questionsHigh-yield facts
ICD-10G90 (G90.9 unspecified; G90.3 multisystem degeneration)
Typical patientYoung woman with dizziness, palpitations on standing
Key findingHeart rate rises ≥30 bpm within 10 min of standing
First-line treatmentIncreased salt/fluid intake, compression garments, exercise
5 min readFor medical studentsUpdated 2026-10-14

Definition and epidemiology

Dysautonomia is an umbrella term for disorders of the autonomic nervous system (ANS), which regulates sympathetic and parasympathetic control of the cardiovascular, gastrointestinal, genitourinary, thermoregulatory, and pupillary systems. It is not a single disease but a spectrum ranging from isolated orthostatic intolerance to widespread autonomic failure.

  • POTS predominantly affects women of reproductive age (roughly 15-50 years), with a female-to-male ratio of about 4-5:1.
  • Neurogenic orthostatic hypotension is more common in older adults, often in the setting of Parkinson disease, multiple system atrophy, or diabetic autonomic neuropathy.
  • Exact prevalence is hard to pin down due to underdiagnosis, but POTS is estimated to affect at least 1-3 million people in the US.
  • Secondary dysautonomia is far more common overall than primary autonomic disorders.
High-yield for exams
  • Orthostatic hypotension = systolic BP drop ≥20 mmHg or diastolic drop ≥10 mmHg within 3 min of standing
  • POTS = heart rate rise ≥30 bpm (≥40 in adolescents) within 10 min of standing WITHOUT hypotension
  • POTS predominantly affects young women; diabetes is the most common cause of secondary autonomic neuropathy
  • Blunted norepinephrine rise on standing points to a neurogenic cause
  • Fludrocortisone and midodrine are mainstay pharmacologic options for orthostatic hypotension
  • Non-pharmacologic measures (salt/fluid, compression, graded exercise) are first-line for POTS
  • Supine hypertension can coexist with orthostatic hypotension in autonomic failure, complicating treatment
  • Rule out cardiac arrhythmia and pheochromocytoma before attributing palpitations/syncope to dysautonomia

Etiology and risk factors

Dysautonomia can be primary (the ANS itself is the target of pathology) or secondary (autonomic dysfunction occurs as a consequence of another disease process).

Primary causes

  • Pure autonomic failure
  • Multiple system atrophy
  • Parkinson disease (autonomic involvement)
  • Familial dysautonomia (hereditary sensory and autonomic neuropathy type III, a rare pediatric genetic disorder)

Secondary causes

  • Diabetes mellitus (most common cause of autonomic neuropathy worldwide)
  • Autoimmune disease (Sjögren syndrome, lupus, autoimmune autonomic ganglionopathy)
  • Amyloidosis
  • Post-viral syndromes, including post-COVID-19 autonomic dysfunction
  • Spinal cord injury
  • Guillain-Barré syndrome
  • Paraneoplastic syndromes
  • Medications (vasodilators, diuretics, alpha-blockers, tricyclic antidepressants)
  • Chronic alcohol use

Risk factors for POTS specifically: recent viral illness, pregnancy, prolonged bed rest/deconditioning, joint hypermobility (Ehlers-Danlos syndrome), and adolescent growth spurts.

Pathophysiology

The ANS has two limbs, sympathetic and parasympathetic, that normally work in balance to maintain homeostasis, particularly blood pressure and heart rate during positional change.

  • On standing, roughly 500-800 mL of blood pools in the lower extremities and splanchnic circulation. Normally, baroreceptors trigger a rapid sympathetic reflex that increases heart rate and vascular tone to maintain cerebral perfusion.
  • In neurogenic orthostatic hypotension, there is failure of norepinephrine release from postganglionic sympathetic neurons, so vascular tone cannot compensate, and blood pressure falls.
  • In POTS, the exact mechanism is debated and likely heterogeneous: proposed mechanisms include excessive peripheral venous pooling, hypovolemia, autoimmune-mediated autonomic injury, and partial sympathetic denervation with compensatory tachycardia.
  • In diabetic autonomic neuropathy, chronic hyperglycemia damages small autonomic nerve fibers, affecting cardiovascular, gastrointestinal, and genitourinary innervation.
  • Autoimmune autonomic ganglionopathy involves antibodies against the ganglionic acetylcholine receptor (gAChR), impairing synaptic transmission in autonomic ganglia.

Clinical features

Symptoms reflect the organ systems under autonomic control and are often diffuse and nonspecific, contributing to diagnostic delay.

Cardiovascular

  • Orthostatic dizziness, presyncope, syncope
  • Palpitations, exercise intolerance
  • Supine hypertension (seen in some neurogenic orthostatic hypotension patients)

Gastrointestinal

  • Gastroparesis (early satiety, nausea, bloating)
  • Constipation or diarrhea
  • Dysphagia

Genitourinary

  • Urinary retention or incontinence
  • Erectile dysfunction

Thermoregulatory and other

  • Anhidrosis or hyperhidrosis
  • Heat intolerance
  • Pupillary abnormalities
  • Brain fog, fatigue (especially prominent in POTS)

Symptoms characteristically worsen with standing, heat, large meals, and prolonged inactivity, and improve with recumbency.

Diagnosis

Diagnosis relies on a combination of bedside orthostatic testing, autonomic function testing, and targeted workup for underlying causes.

Bedside orthostatic vital signs

  • Measure blood pressure and heart rate supine, then at 1 and 3 minutes after standing (or head-up tilt).
  • Orthostatic hypotension: sustained drop in systolic BP ≥20 mmHg or diastolic BP ≥10 mmHg within 3 minutes of standing.
  • POTS: sustained heart rate increase ≥30 bpm (≥40 bpm in adolescents) within 10 minutes of standing, without orthostatic hypotension.

Further testing

  • Tilt-table testing confirms the diagnosis when bedside measurements are equivocal.
  • Autonomic function testing (heart rate variability, Valsalva maneuver response, quantitative sudomotor axon reflex test, or QSART) assesses sympathetic and parasympathetic integrity.
  • Laboratory workup to exclude secondary causes: HbA1c/glucose, thyroid function, B12, ANA and other autoimmune markers, serum/urine protein electrophoresis if amyloidosis suspected, paraneoplastic antibody panel if indicated.
  • Plasma catecholamines (supine and standing) can help distinguish neurogenic (blunted norepinephrine rise) from non-neurogenic causes.
  • Gastric emptying study (preceded by upper endoscopy to exclude mechanical obstruction) if gastroparesis is suspected.
  • Echocardiogram or Holter monitor to exclude primary cardiac causes of palpitations/syncope before labeling as dysautonomia.

Differential diagnosis

  • Inappropriate sinus tachycardia: elevated resting heart rate without the orthostatic trigger pattern of POTS
  • Vasovagal (reflex) syncope: triggered by pain/emotion, brief prodrome, rapid recovery
  • Anxiety/panic disorder: can mimic palpitations and dizziness but lacks consistent orthostatic hemodynamic changes
  • Pheochromocytoma: episodic hypertension, palpitations, diaphoresis
  • Hypovolemia/dehydration: mimics orthostatic intolerance but resolves with volume repletion
  • Addison disease: orthostatic hypotension with hyperpigmentation, hyperkalemia, hyponatremia
  • Cardiac arrhythmia: palpitations and syncope independent of position
  • Mast cell activation syndrome: overlapping flushing, tachycardia, often coexists with POTS

Management

Management is tailored to the specific autonomic phenotype (POTS vs. neurogenic orthostatic hypotension) and underlying cause; a treat-the-cause approach is prioritized when a secondary etiology is identified (e.g., glycemic control in diabetes, immunotherapy in autoimmune ganglionopathy).

Non-pharmacologic (first-line for most patients)

  • Increased salt (sodium) and fluid intake
  • Compression stockings/abdominal binders to reduce venous pooling
  • Graded aerobic exercise program (recumbent or reclined exercise initially in POTS, progressing to upright)
  • Avoidance of triggers: prolonged standing, heat, large carbohydrate-heavy meals, alcohol
  • Physical counter-maneuvers (leg crossing, muscle tensing) before standing
  • Elevating the head of the bed for neurogenic orthostatic hypotension

Pharmacologic

  • Fludrocortisone: expands plasma volume, used in both POTS and neurogenic orthostatic hypotension
  • Midodrine: peripheral alpha-1 agonist, raises standing blood pressure
  • Droxidopa: norepinephrine precursor, approved for neurogenic orthostatic hypotension
  • Beta-blockers (low-dose) or ivabradine: reduce heart rate in POTS
  • Pyridostigmine: enhances ganglionic transmission, used in some POTS and autonomic neuropathy patients
  • Treatment of underlying cause (immunosuppression for autoimmune ganglionopathy, glycemic optimization in diabetes)

Guideline consensus (American Autonomic Society, Heart Rhythm Society) emphasizes starting with non-pharmacologic measures and reserving medications for persistent, functionally limiting symptoms. There is no single approved cure; treatment is symptom-directed and individualized.

Complications and prognosis

  • Falls and fall-related injury from syncope/presyncope
  • Significant impact on quality of life and functional capacity, particularly in POTS (comparable disability to some cardiopulmonary diseases in severe cases)
  • Malnutrition and weight loss from severe gastroparesis
  • Progression of underlying neurodegenerative disease (e.g., multiple system atrophy carries a poor overall prognosis independent of the autonomic features)
  • POTS in adolescents and young adults often improves or resolves over several years with treatment, especially when triggered by a viral illness
  • Neurogenic orthostatic hypotension from neurodegenerative disease tends to be progressive and chronic
Mnemonic

POTS mnemonic — "FAST": Fluids/salt, Avoid triggers (heat, prolonged standing), Stockings (compression), Training (graded exercise)

Practice questions

1. A 22-year-old woman presents with a 1-year history of lightheadedness, palpitations, and fatigue upon standing, which improve when she sits down. Supine heart rate is 72 bpm and blood pressure is 118/72 mmHg. After standing for 10 minutes, heart rate is 108 bpm and blood pressure is 112/70 mmHg. She has no history of syncope. Which of the following is the most likely diagnosis?

Answer: B. The patient has a heart rate increase of 36 bpm on standing (≥30 bpm threshold) without a significant drop in blood pressure, which is diagnostic of POTS. Neurogenic orthostatic hypotension is excluded because blood pressure remains stable. Inappropriate sinus tachycardia is a resting tachycardia independent of posture, which does not fit this orthostatic pattern.

2. A 68-year-old man with a 10-year history of Parkinson disease reports recurrent dizziness and near-fainting spells whenever he stands up, especially in the morning. Supine blood pressure is 150/90 mmHg; after standing for 2 minutes, blood pressure is 110/65 mmHg with little change in heart rate. Which mechanism best explains this finding?

Answer: C. This presentation is classic for neurogenic orthostatic hypotension due to Parkinson disease-associated autonomic failure. The lack of a compensatory heart rate rise despite a significant BP drop indicates impaired sympathetic efferent (noradrenergic) function rather than a volume or cardiac rhythm problem. Supine hypertension coexisting with orthostatic hypotension is a recognized feature of neurogenic autonomic failure.

3. A 45-year-old woman with longstanding type 1 diabetes mellitus (HbA1c consistently >9%) reports early satiety, bloating, and intermittent nausea for the past 8 months, along with occasional orthostatic dizziness. An upper endoscopy performed to evaluate these symptoms shows no mechanical obstruction, ulcer, or malignancy. Which of the following is the most appropriate next diagnostic step to confirm the suspected gastrointestinal complication?

Answer: B. The clinical picture (early satiety, bloating, nausea in a patient with longstanding poorly controlled diabetes) suggests diabetic gastroparesis, a manifestation of diabetic autonomic neuropathy. Once endoscopy has excluded a mechanical cause, a gastric emptying study (typically scintigraphy) is the standard test used to confirm delayed gastric emptying and establish the diagnosis of gastroparesis.

Frequently asked questions

What causes dysautonomia?

Dysautonomia results from dysfunction of the autonomic nervous system, which can be primary (idiopathic, genetic, or neurodegenerative, as in multiple system atrophy) or secondary to another condition. Common secondary causes include diabetes mellitus, autoimmune disease, viral infections (including post-COVID-19), amyloidosis, and certain medications. In POTS specifically, triggers often include viral illness, pregnancy, or prolonged bed rest.

What are the first symptoms of dysautonomia?

The earliest symptoms are usually orthostatic: lightheadedness, dizziness, or palpitations when standing up, along with fatigue and exercise intolerance. Many patients also notice brain fog, heat intolerance, and gastrointestinal symptoms like nausea or bloating. Symptoms characteristically worsen with prolonged standing, heat, and large meals, and improve when lying down.

How is dysautonomia diagnosed?

Diagnosis starts with bedside orthostatic vital signs, comparing blood pressure and heart rate supine versus after standing for several minutes. Tilt-table testing confirms borderline cases, and autonomic function tests (heart rate variability, QSART, Valsalva response) assess the extent of dysfunction. Blood work screens for underlying causes like diabetes, autoimmune disease, or amyloidosis.

Is dysautonomia curable?

Most forms of dysautonomia are not curable but are manageable with lifestyle measures and medications that control symptoms. POTS, especially when triggered by a viral illness in younger patients, often improves substantially or resolves over several years. Dysautonomia caused by progressive neurodegenerative disease (like multiple system atrophy) tends to worsen over time regardless of treatment.

POTS vs. orthostatic hypotension — what is the difference?

POTS features a marked rise in heart rate (≥30 bpm, or ≥40 bpm in adolescents) on standing without a significant drop in blood pressure, while orthostatic hypotension is defined by a sustained fall in blood pressure (systolic ≥20 mmHg or diastolic ≥10 mmHg) on standing, with or without a compensatory tachycardia. They can occasionally coexist, but the hemodynamic pattern distinguishes them and guides different treatment emphasis.

Key drugs

FludrocortisoneMidodrineDroxidopaPyridostigminePropranololIvabradineDesmopressinOctreotide
Postural orthostatic tachycardia syndrome (POTS)Multiple system atrophyDiabetic autonomic neuropathyAutoimmune autonomic ganglionopathyVasovagal syncopeGuillain-Barré syndromeEhlers-Danlos syndromePure autonomic failure

Sources and further reading

StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: G90

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.